5-127396728-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_001256545.2(MEGF10):​c.609C>T​(p.Cys203Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0115 in 1,614,048 control chromosomes in the GnomAD database, including 117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0082 ( 7 hom., cov: 32)
Exomes 𝑓: 0.012 ( 110 hom. )

Consequence

MEGF10
NM_001256545.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.830

Publications

3 publications found
Variant links:
Genes affected
MEGF10 (HGNC:29634): (multiple EGF like domains 10) This gene encodes a member of the multiple epidermal growth factor-like domains protein family. The encoded protein plays a role in cell adhesion, motility and proliferation, and is a critical mediator of apoptotic cell phagocytosis as well as amyloid-beta peptide uptake in the brain. Expression of this gene may be associated with schizophrenia, and mutations in this gene are a cause of early-onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD) as well as congenital myopathy with minicores. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Apr 2012]
MEGF10 Gene-Disease associations (from GenCC):
  • MEGF10-related myopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 5-127396728-C-T is Benign according to our data. Variant chr5-127396728-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 262078.
BP7
Synonymous conserved (PhyloP=-0.83 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00821 (1251/152342) while in subpopulation NFE AF = 0.0126 (858/68026). AF 95% confidence interval is 0.0119. There are 7 homozygotes in GnomAd4. There are 542 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001256545.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEGF10
NM_001256545.2
MANE Select
c.609C>Tp.Cys203Cys
synonymous
Exon 6 of 25NP_001243474.1
MEGF10
NM_032446.3
c.609C>Tp.Cys203Cys
synonymous
Exon 7 of 26NP_115822.1
MEGF10
NM_001308119.2
c.609C>Tp.Cys203Cys
synonymous
Exon 7 of 15NP_001295048.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEGF10
ENST00000503335.7
TSL:1 MANE Select
c.609C>Tp.Cys203Cys
synonymous
Exon 6 of 25ENSP00000423354.2
MEGF10
ENST00000274473.6
TSL:1
c.609C>Tp.Cys203Cys
synonymous
Exon 7 of 26ENSP00000274473.6
MEGF10
ENST00000418761.6
TSL:1
c.609C>Tp.Cys203Cys
synonymous
Exon 7 of 15ENSP00000416284.2

Frequencies

GnomAD3 genomes
AF:
0.00822
AC:
1252
AN:
152224
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00232
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.00615
Gnomad ASJ
AF:
0.0306
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00583
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0126
Gnomad OTH
AF:
0.00955
GnomAD2 exomes
AF:
0.00858
AC:
2153
AN:
250822
AF XY:
0.00858
show subpopulations
Gnomad AFR exome
AF:
0.00192
Gnomad AMR exome
AF:
0.00654
Gnomad ASJ exome
AF:
0.0356
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00605
Gnomad NFE exome
AF:
0.0117
Gnomad OTH exome
AF:
0.00833
GnomAD4 exome
AF:
0.0118
AC:
17285
AN:
1461706
Hom.:
110
Cov.:
33
AF XY:
0.0118
AC XY:
8545
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.00149
AC:
50
AN:
33480
American (AMR)
AF:
0.00646
AC:
289
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0364
AC:
952
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00144
AC:
124
AN:
86254
European-Finnish (FIN)
AF:
0.00672
AC:
358
AN:
53274
Middle Eastern (MID)
AF:
0.00433
AC:
25
AN:
5768
European-Non Finnish (NFE)
AF:
0.0133
AC:
14756
AN:
1111974
Other (OTH)
AF:
0.0121
AC:
729
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
919
1838
2757
3676
4595
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00821
AC:
1251
AN:
152342
Hom.:
7
Cov.:
32
AF XY:
0.00728
AC XY:
542
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00231
AC:
96
AN:
41588
American (AMR)
AF:
0.00614
AC:
94
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0306
AC:
106
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00583
AC:
62
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0126
AC:
858
AN:
68026
Other (OTH)
AF:
0.00945
AC:
20
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
70
139
209
278
348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0110
Hom.:
6
Bravo
AF:
0.00821
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0135
EpiControl
AF:
0.0134

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
Dec 26, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 29, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Apr 05, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MEGF10-related myopathy Uncertain:1Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

not provided Benign:1
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MEGF10: BP4, BP7, BS1, BS2

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
8.3
DANN
Benign
0.60
PhyloP100
-0.83
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113794264; hg19: chr5-126732420; API